MANAGEMENT OF HIGH-DOSE MELPHALAN-INDUCED ORAL MUCOSITIS: OUR EXPERIENCE

被引：0
|
作者：
Tartarone, Alfredo [1 ]
Matera, Rosella [1 ]
Iodice, Giovanni [1 ]
Romano, Gianpiero [1 ]
Coccaro, Maria [1 ]
Capobianco, Alba [1 ]
Bochicchio, Annamaria [1 ]
Vigliotti, Maria Luigia [1 ]
Mele, Giuseppe [1 ]
Di Leo, Pasquale [1 ]
Musto, Clelia [1 ]
Di Renzo, Nicola [1 ]
机构：
[1] Ctr Riferimento Oncol Basilicata, Div Oncoematol, Rionero In Vulture, PZ, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy
    Gustavo Henrique Rodrigues
    Graziella Chagas Jaguar
    Fabio Abreu Alves
    Andre Guollo
    Vanessa Oliveira Camandoni
    Aline Santos Damascena
    Vladmir Claudio Cordeiro Lima
    Lasers in Medical Science, 2017, 32 : 1089 - 1095
  • [32] In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden
    Blijlevens, N.
    de Chateau, M.
    Krivan, G.
    Rabitsch, W.
    Szomor, A.
    Pytlik, R.
    Lissmats, A.
    Johnsen, H. E.
    de Witte, T.
    Einsele, H.
    Ruutu, T.
    Niederwieser, D.
    BONE MARROW TRANSPLANTATION, 2013, 48 (07) : 966 - 971
  • [33] In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden
    N Blijlevens
    M de Château
    G Krivan
    W Rabitsch
    A Szomor
    R Pytlik
    A Lissmats
    H E Johnsen
    T de Witte
    H Einsele
    T Ruutu
    D Niederwieser
    Bone Marrow Transplantation, 2013, 48 : 966 - 971
  • [34] Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy
    Rodrigues, Gustavo Henrique
    Jaguar, Graziella Chagas
    Alves, Fabio Abreu
    Guollo, Andre
    Camandoni, Vanessa Oliveira
    Damascena, Aline Santos
    Cordeiro Lima, Vladmir Claudio
    LASERS IN MEDICAL SCIENCE, 2017, 32 (05) : 1089 - 1095
  • [35] INTRAPATIENT AND INTERPATIENT VARIABILITY IN PHARMACOKINETICS OF HIGH-DOSE ORAL MELPHALAN
    CHOI, K
    RATAIN, M
    WILLIAMS, S
    GOLICK, J
    BITRAN, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (02) : 193 - 193
  • [36] Melphalan-Induced Intestinal Mucositis in Autologous Hematopoietic Stem Cell Transplant: Rapid Response to Short Course of Oral Budesonide
    Ingole, P.
    Morkas, M.
    May, R.
    Hinman, B.
    Carrum, G.
    Kamble, R. T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S587 - S587
  • [37] ORAL COMPLICATIONS OF HIGH-DOSE MELPHALAN IN MULTIPLE-MYELOMA
    BARRETT, AP
    BUCKLEY, DJ
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1987, 64 (02): : 264 - 267
  • [38] EFFICACY OF APREPITANT IN PREVENTING HIGH-DOSE MELPHALAN-INDUCED NAUSEA AND VOMITING IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Sakurai, M.
    Mori, T.
    Kato, J.
    Yamane, A.
    Kohashi, S.
    Okamoto, S.
    HAEMATOLOGICA, 2012, 97 : 722 - 723
  • [39] STUDIES WITH HIGH-DOSE MELPHALAN
    MCELWAIN, T
    CANCER TREATMENT REVIEWS, 1979, 6 : 149 - 150
  • [40] Prospective oral mucositis audit (POMA):: Occurrence and consequences of severe oral mucositis in high dose melphalan and BEAM conditioning.
    Blijlevens, Nicole N. A.
    McCann, Shaun
    Bacon, Pam
    Cinneide, Roisin
    Quinn, Barry
    Roosaar, Ann
    Schouten, Harry
    Schwenkglenks, Matthias
    Stone, Rebecca
    BLOOD, 2006, 108 (11) : 18A - 19A
12345